Margaret C. Fisher

TL;DR: Data are insufficient to recommend routine administration of PCV7 for children at moderate risk of pneumococcal invasive infection, including all children 24 to 35 months old, children who attend out-of-home care, and children 36 to 59 months old who are of Native American (American Indian and Alaska Native) or African American descent.

TL;DR: Recommendations for its use are based on a large, randomized study demonstrating a 55% reduction in the risk of hospitalization attributable to respiratory syncytial virus (RSV) infections in high-risk pediatric patients, and discontinuation of injections for adverse events related to palivizumab was rare.

TL;DR: Recommendations for immunoprophylaxis have been updated in an effort to ensure optimal balance of benefit and cost from this expensive intervention and are consistent with the 2009 Red Book recommendations.

TL;DR: This report presents the recommended childhood immunization schedule for 2002, which has remained the same in content since January 2001 but has a redesigned format.

TL;DR: Recommendations are provided regarding the use of Rv vaccine in infants in the United States and trials of rhesus rotavirus-tetravalent (Rv) vaccine show efficacy rates that are similar to the protection observed after natural Rv infection.